141 related articles for article (PubMed ID: 38547077)
1. Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
Griffin JI; Chen X; Duan L; Mu Q; Ho RJY
PLoS One; 2024; 19(3):e0300723. PubMed ID: 38547077
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel.
Jiang YJ; Lee CL; Wang Q; Zhou ZW; Yang F; Jin C; Fu DL
World J Gastroenterol; 2014 Jul; 20(28):9476-85. PubMed ID: 25071342
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma.
Hay CA; Sor R; Flowers AJ; Clendenin C; Byrne KT
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31814615
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy.
Erstad DJ; Sojoodi M; Taylor MS; Ghoshal S; Razavi AA; Graham-O'Regan KA; Bardeesy N; Ferrone CR; Lanuti M; Caravan P; Tanabe KK; Fuchs BC
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29903803
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma.
Nikfarjam M; Yeo D; He H; Baldwin G; Fifis T; Costa P; Tan B; Yang E; Wen Sw; Christophi C
J Invest Surg; 2013 Dec; 26(6):352-9. PubMed ID: 23957638
[TBL] [Abstract][Full Text] [Related]
6. Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.
Ma Y; Li J; Wang H; Chiu Y; Kingsley CV; Fry D; Delaney SN; Wei SC; Zhang J; Maitra A; Yee C
Gastroenterology; 2020 Jul; 159(1):306-319.e12. PubMed ID: 32179091
[TBL] [Abstract][Full Text] [Related]
7. Discrepancies in the Tumor Microenvironment of Spontaneous and Orthotopic Murine Models of Pancreatic Cancer Uncover a New Immunostimulatory Phenotype for B Cells.
Spear S; Candido JB; McDermott JR; Ghirelli C; Maniati E; Beers SA; Balkwill FR; Kocher HM; Capasso M
Front Immunol; 2019; 10():542. PubMed ID: 30972056
[TBL] [Abstract][Full Text] [Related]
8. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
[TBL] [Abstract][Full Text] [Related]
9. An orthotopic model of ductal adenocarcinoma of the pancreas in severe combined immunodeficient mice representing all steps of the metastatic cascade.
Alves F; Contag S; Missbach M; Kaspareit J; Nebendahl K; Borchers U; Heidrich B; Streich R; Hiddemann W
Pancreas; 2001 Oct; 23(3):227-35. PubMed ID: 11590317
[TBL] [Abstract][Full Text] [Related]
10. Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model.
Shankara Narayanan JS; Vicente DA; Ray P; Chai LF; Erdem S; Carr MJ; Capacio BA; Cox BF; Jaroch DB; Katz SC; White RR
Surgery; 2020 Sep; 168(3):448-456. PubMed ID: 32620306
[TBL] [Abstract][Full Text] [Related]
11. The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
Dineen SP; Sullivan LA; Beck AW; Miller AF; Carbon JG; Mamluk R; Wong H; Brekken RA
BMC Cancer; 2008 Nov; 8():352. PubMed ID: 19038046
[TBL] [Abstract][Full Text] [Related]
12. Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer.
Schmitt C; Saur D; Bärthel S; Falcomatà C
J Vis Exp; 2022 Oct; (188):. PubMed ID: 36282716
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
14. Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice.
Doi C; Maurya DK; Pyle MM; Troyer D; Tamura M
Cytotherapy; 2010 May; 12(3):408-17. PubMed ID: 20345214
[TBL] [Abstract][Full Text] [Related]
15. Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.
Tseng WW; Winer D; Kenkel JA; Choi O; Shain AH; Pollack JR; French R; Lowy AM; Engleman EG
Clin Cancer Res; 2010 Jul; 16(14):3684-95. PubMed ID: 20534740
[TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
[TBL] [Abstract][Full Text] [Related]
17. Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.
Gnerlich JL; Mitchem JB; Weir JS; Sankpal NV; Kashiwagi H; Belt BA; Porembka MR; Herndon JM; Eberlein TJ; Goedegebuure P; Linehan DC
J Immunol; 2010 Oct; 185(7):4063-71. PubMed ID: 20805420
[TBL] [Abstract][Full Text] [Related]
18. TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
Perez-Penco M; Weis-Banke SE; Schina A; Siersbæk M; Hübbe ML; Jørgensen MA; Lecoq I; Lara de la Torre L; Bendtsen SK; Martinenaite E; Holmström MO; Madsen DH; Donia M; Ødum N; Grøntved L; Andersen MH
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600556
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.
Moo-Young TA; Larson JW; Belt BA; Tan MC; Hawkins WG; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunother; 2009 Jan; 32(1):12-21. PubMed ID: 19307989
[TBL] [Abstract][Full Text] [Related]
20. Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
Walters DM; Stokes JB; Adair SJ; Stelow EB; Borgman CA; Lowrey BT; Xin W; Blais EM; Lee JK; Papin JA; Parsons JT; Bauer TW
PLoS One; 2013; 8(10):e77065. PubMed ID: 24204737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
